Vaccines against persistent DNA virus infections
Open Access
- 1 July 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in British Medical Bulletin
- Vol. 62 (1) , 125-138
- https://doi.org/10.1093/bmb/62.1.125
Abstract
Persistent viruses present some particular problems for vaccine design. As for acute non-persistent viruses, the prime goal of a vaccine should be to prevent primary infection. Vaccines might also be used to modify the course of established persistent virus infections – so-called postinfective immunisation. This chapter deals with selected persistent DNA viruses, in particular the human herpes viruses.Keywords
This publication has 52 references indexed in Scilit:
- Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphomaInternational Journal of Cancer, 2001
- The immunology of Epstein–Barr virus infectionPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- The Effectiveness of the Varicella Vaccine in Clinical PracticeNew England Journal of Medicine, 2001
- A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2New England Journal of Medicine, 1999
- A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New AdjuvantThe Journal of Infectious Diseases, 1999
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 DiseaseThe Journal of Infectious Diseases, 1997
- Analysis of the Proliferative T Cell Response to Human Cytomegalovirus Major Immediate‐Early Protein (IEl): Phenotype, Frequeney and Variability*Scandinavian Journal of Immunology, 1995
- In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in RodentsThe Journal of Infectious Diseases, 1988
- Live Attenuated Varicella Virus VaccineNew England Journal of Medicine, 1984